TAG advocates for responsible public policy on AIDS research and treatment with our nation's leaders, including members of Congress and officials from the relevant agencies in the Executive Branch. We push for more funding for AIDS research and sensible legislative initiatives to foster better biomedical research. TAG also advocates for sound regulatory policy in the evaluation of AIDS drugs which balances the need for access to new agents and the need for reliable information about their clinical efficacy.